Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Datasets
Prizes
Activities
Press / Media
Equipment
Search by expertise, name or affiliation
Do adult human oligodendrocytes remyelinate poorly and can we change this to better treat progressive multiple sclerosis?
Williams, Anna
(Principal Investigator)
Deanery of Clinical Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/12/19
→
31/01/23
Funding
MRC:
£762,030.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Oligodendroglia
Medicine & Life Sciences
100%
Central Nervous System
Medicine & Life Sciences
67%
Neuropathology
Medicine & Life Sciences
25%
Neurodegenerative Diseases
Medicine & Life Sciences
19%
Learning
Medicine & Life Sciences
16%
Brain
Medicine & Life Sciences
11%
Health
Medicine & Life Sciences
11%
Therapeutics
Medicine & Life Sciences
7%
Research output
Research output per year
2021
2021
2021
1
Article
Research output per year
Research output per year
Oligodendroglia heterogeneity in the human central nervous system
Seeker, L.
&
Williams, A. C.
,
3 Dec 2021
,
In:
Acta Neuropathologica.
143
,
p. 143-157
15 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Oligodendroglia
100%
Central Nervous System
67%
Neuropathology
25%
Neurodegenerative Diseases
19%
Learning
16%